BNP Paribas Financial Markets’s iBio IBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding IBIO
AAA
FLSM
EC
LGM
VCM
IC
SCM
BNP Paribas Financial Markets's IBIO Position: Q1 2026 in Review
BNP Paribas Financial Markets held its iBio (IBIO) position steady in Q1 2026 at 5 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #5767.
BNP Paribas Financial Markets first reported a position in IBIO in Q2 2020 and has held it in 18 quarters since. The position peaked at $64.9K in Q3 2021. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.
- BNP Paribas Financial Markets held 5 shares of iBio worth $10 as of Q1 2026.
- BNP Paribas Financial Markets left its iBio share count unchanged in Q1 2026.
- iBio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5767 holding.
- BNP Paribas Financial Markets first reported a position in iBio in Q2 2020 and has held it in 18 quarters since.
- BNP Paribas Financial Markets's iBio position peaked at $64.9K in Q3 2021.
- 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.